HOPE Therapeutics treats first patient using Zeta TMS Navigation System

NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc.

NRXP

0.00
  • HOPE Therapeutics, a unit of NRX Pharmaceuticals, treated its first patient using Zeta Surgical’s FDA-cleared Zeta TMS Navigation System.
  • HOPE installed the system at clinics in Sarasota and West Palm Beach, with Zeta-navigated treatments starting this week at both sites.
  • The platform uses RealTrack technology to align MRI or CT scans to facial anatomy in under two minutes, guiding TMS coil placement with sub-millimetric accuracy.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606231105PR_NEWS_USPR_____NE90229) on June 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.